| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 04/06/2009 | 13:05 | PR Newswire (US) | Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 30/01/2008 | 13:00 | PR Newswire (US) | Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc. | NASDAQ:ARXT | |
| 30/01/2008 | 12:03 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc.-removal from listing & reg. of matured, redeemed/retired sec. Initial Filing Ame.. (25-NSE) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 29/01/2008 | 15:55 | PR Newswire (US) | QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Inde | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 25/01/2008 | 22:44 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 24/01/2008 | 13:00 | PR Newswire (US) | Reckitt Benckiser Announces Completion of Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics, Inc. | NASDAQ:ARXT | |
| 22/01/2008 | 22:22 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Statement of Beneficial Ownership (SC 13D) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 18/01/2008 | 23:13 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 18/01/2008 | 20:38 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 15/01/2008 | 19:55 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Statement of Ownership (SC 13G) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 08/01/2008 | 13:00 | PR Newswire (US) | Reckitt Benckiser Receives Hart-Scott-Rodino Antitrust Clearance for Acquisition of Adams Respiratory Therapeutics | NASDAQ:ARXT | |
| 21/12/2007 | 21:49 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 21/12/2007 | 21:16 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Tender offer statement by Third Party (SC TO-T) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 14/12/2007 | 22:08 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 14/12/2007 | 21:07 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc.-Written communication by the subject co. relating to a third party tender offer (SC14D9C) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 10/12/2007 | 20:50 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Current report filing (8-K) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 10/12/2007 | 13:07 | PR Newswire (US) | Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser | NASDAQ:ARXT | |
| 14/11/2007 | 14:00 | PR Newswire (US) | Nashville Based DaySpring Pharma Announces Two New Board Members | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 13/11/2007 | 14:57 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. (Other) (4) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 09/11/2007 | 21:58 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Quarterly Report (10-Q) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 08/11/2007 | 15:07 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Current report filing | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 08/11/2007 | 12:30 | PR Newswire (US) | Adams Respiratory Therapeutics Reports Fiscal 2008 First Quarter Results | NASDAQ:ARXT | |
| 29/10/2007 | 22:28 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Proxy Statement (definitive) (DEF 14A) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 29/10/2007 | 22:28 | Edgar (US Regulatory) | Adams Respiratory Therapeutics, Inc. - Proxy Statement (definitive) | NASDAQ:ARXT | Adams Respiratory Therapeutics (MM) |
| 29/10/2007 | 11:00 | PR Newswire (US) | Adams Respiratory Therapeutics Receives Approvable Letter From FDA for Mucinex(R) With Codeine | NASDAQ:ARXT | |
| 15/10/2007 | 23:00 | PR Newswire (US) | Adams Respiratory Therapeutics Schedules Conference Call and Webcast for Fiscal First Quarter 2008 Earnings | NASDAQ:ARXT | |
| 01/10/2007 | 13:45 | PR Newswire (US) | Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R) | NASDAQ:ARXT | |
| 27/09/2007 | 14:40 | PR Newswire (US) | Adams Respiratory Therapeutics Files Lawsuit Against Perrigo for Infringement of Mucinex(R) Patent | NASDAQ:ARXT | |
| 19/09/2007 | 14:00 | PR Newswire (US) | Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement | NASDAQ:ARXT | |
| 21/08/2007 | 12:35 | PR Newswire (US) | Adams Respiratory Therapeutics Reports Fiscal 2007 Fourth Quarter and Year-End Financial Results | NASDAQ:ARXT | |